INDmoney
Nektar Therapeutics Stock Performance
as on February 6, 2026 at 2:29 am IST
Day's Low
Day's High
$34.90$38.47
0.54%
Downside
9.63%
Upside
52 Week's Low
52 Week's High
$6.48$66.9281.53%
Downside
90.71%
Upside
Nektar Therapeutics share price movements today
- Previous Close
- $37.64
- Open
- $37.74
- Volume
- 898.7K
- Day's Low - High
- $34.90 - $38.47
- 52 Week Low - High
- $6.48 - $66.92
Nektar Therapeutics Historical Returns
- 1 Month Return
- -15.36 %
- 3 Month Return
- -30.63 %
- 1 Year Return
- + 230.18 %
- 3 Year Return
- -18.79 %
- 5 Year Return
- -87.57 %
Nektar Therapeutics Stock Fundamentals & Key Indicators
Check Nektar Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$756.3M
EPS (TTM)
-8.32
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.32
Industry PE ratio
-2.821844380403458
PEG Ratio
3.22
EBITDA
-135.2M
Revenue (TTM)
62.6M
Profit Margin
-192.87%
Return On Equity TTM
-180.24%
Nektar Therapeutics Stock Valuation
Track how Nektar Therapeutics P/E has moved over time to understand its valuation trends.
Nektar Therapeutics in the last 5 years
Lowest (-130.77x)
March 31, 2021
Industry (-2.82x)
February 5, 2026
Today (-1.32x)
February 5, 2026
Highest (-3.19x)
June 30, 2025
Today’s Price to Earnings Ratio: -1.32x
Nektar Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Nektar Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $756.3M | -87.57% | -1.32 | -192.87% | |
| BUY | $47.7B | 113.17% | 1246.03 | 1.36% | |
| BUY | $122.3B | 118.58% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 55.33% | 18.28 | 32.13% |
Stock Returns calculator for Nektar Therapeutics Stock including INR - Dollar returns
The Nektar Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Nektar Therapeutics investment value today
Current value as on today
₹3,11,175
Returns
₹2,11,175
(+211.18%)
Returns from Nektar Therapeutics Stock
₹2,07,807 (+207.81%)
Dollar Returns*
₹3,368 (+3.37%)
Analyst Recommendation on Nektar Therapeutics Stock
Based on 9 analysts
0.00%
Buy
55.56%
Hold
44.44%
Sell
Based on 9 analysts, 55.56% of analysts recommend a 'HOLD' rating for Nektar Therapeutics. Average target price of $114.43
Nektar Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Nektar Therapeutics.
What analysts predicted
69.33%UPSIDE
Target Price
$114.43
Current Price
$35.09
Analyzed by
9 Analysts
Target
$114.43
Nektar Therapeutics target price $114.43, a slight upside of 69.33% compared to current price of $35.09. According to 9 analysts rating.
Nektar Therapeutics Stock’s Investor Sentiment and Interest
Search interest for Nektar Therapeutics Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Nektar Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Nektar Therapeutics Annual Profit & Loss
All numbers in Millions USD
Nektar Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Nektar Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Nektar Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, NKTR stock has moved up by 67.7%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NKTR has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -50.88M → -35.52M (in $), with an average increase of 19.7% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 10.46M → 11.79M (in $), with an average increase of 5.8% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 43.6% return, outperforming this stock by 62.4%
About Nektar Therapeutics
| Organisation | Nektar Therapeutics |
| Headquarters | 455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158 |
| Industry | Health Technology |
| CEO | Mr. Howard W. Robin |
| E-voting on shares | Click here to vote |
Key Management of Nektar Therapeutics
Name | Title |
|---|---|
Mr. Jason Barnard | Chief Accounting Officer |
Ms. Elizabeth Zhang | VP of Legal & Corporate Counsel |
Ms. Jennifer Ruddock | Chief Business Officer |
Dr. Ken Franke Ph.D. | Senior Vice President of Biologics Process Development & Manufacturing |
Ms. Charleen Jue | Senior Vice President of Clinical Development Operations |
Ms. Sandra A. Gardiner | CFO and Principal Financial & Accounting Officer |
Dr. Jonathan Zalevsky Ph.D. | Senior VP and Chief Research & Development Officer |
Dr. Mary Tagliaferri L.Ac., M.D. | Chief Medical Officer |
Mr. Howard W. Robin | CEO, President & Director |
Mr. Robert Bacci | Chief People Officer and Head of Quality & Facilities |
FAQs
What is Nektar Therapeutics share price today?
Nektar Therapeutics share price today is $35.09 as on at the close of the market. Nektar Therapeutics share today touched a day high of $38.47 and a low of $34.9.
What is the 52 week high and 52 week low for Nektar Therapeutics share?
Nektar Therapeutics share touched a 52 week high of $66.92 on and a 52 week low of $6.48 on . Nektar Therapeutics stock price today i.e. is closed at $35.09,which is 47.56% down from its 52 week high and 441.51% up from its 52 week low.
What is Nektar Therapeutics's market capitalisation today?
Nektar Therapeutics market capitalisation is $0.00T as on .
How to invest in Nektar Therapeutics Stock (NKTR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Nektar Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nektar Therapeutics Shares that will get you 0.0427 shares as per Nektar Therapeutics share price of $35.09 per share as on February 6, 2026 at 2:29 am IST.
What is the minimum amount required to buy Nektar Therapeutics Stock (NKTR) from India?
Indian investors can start investing in Nektar Therapeutics (NKTR) shares with as little as ₹90.283 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.83 in Nektar Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Nektar Therapeutics share’s latest price of $35.09 as on February 6, 2026 at 2:29 am IST, you will get 0.2850 shares of Nektar Therapeutics. Learn more about
fractional shares .
What are the returns that Nektar Therapeutics has given to Indian investors in the last 5 years?
Nektar Therapeutics stock has given -87.57% share price returns and 25.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?